December 28, 2011
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) and Mirna Therapeutics, Inc. Announce License Agreement for Up to $63 Million for the Development
December 23, 2011
A look back, and forward
December 19, 2011
Roche’s Zelboraf Melanoma Drug Wins Backing of EU Regulator
December 19, 2011
Emil Kakkis harvesting academic sources for Orphan drug newco Ultragenyx
December 13, 2011
Nanotechnology firm Liquidia partners with PATH on new pneumonia vaccine
December 12, 2011
Plexxikon Inc. Advances Novel Targeted Treatment PLX3397 in Blood Cancer
December 9, 2011
CeNeRx, expecting trial results and drug partner in 2012, raises $4.8M
December 8, 2011
Finding satisfaction in stratification
December 8, 2011
Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer
December 1, 2011
Anthera Pharmaceuticals Completes Interim B-Cell Analysis of PEARL-SC Study
November 29, 2011
More Big Foundations Are Investing in For-Profits
November 21, 2011
Achillion to Present at the 23rd Annual Piper Jaffray Health Care Conference
November 15, 2011
CardioDx Passes Trial, Determining When Chest Pain Is No Big Deal
November 13, 2011
Benefit of Novel Drug in Breast Cancer Seen in Blood Within Weeks
October 26, 2011
Anthera Pharmaceuticals, Inc. (ANTH) Announces Last Patient Enrolled in PEARL-SC Study
October 7, 2011
Plexxikon’s Glaub: personalized medicine is ‘the wave of the future’
September 16, 2011
Chimerix Announces Late-Breaker Presentation At 51st Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC) Annual Meeting
September 6, 2011
Syndax Pharmaceutical's Positive Phase 2 Data Supports Potential For Entinostat In Advanced Breast Cancer
September 6, 2011
Tesaro - 2011 Fierce 15
August 30, 2011
CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million
August 20, 2011
CoLucid Pharmaceuticals Receives Clearance For Investigational New Drug (IND) Application For Lasmiditan For The Treatment Of Acute Migraine
August 18, 2011
CoLucid in talks with partners for novel migraine treatment
August 17, 2011
Genentech, Plexxikon Cancer Drug Gets FDA OK
August 17, 2011
Syndax Pharmaceuticals Inc. Announces Issuance of EU Patent for Entinostat
August 10, 2011
Vemurafenib Will Open Floodgates for Melanoma Genotyping
July 15, 2011
CoLucid Appoints Thomas P. Mathers as Chief Executive Officer Read more: CoLucid Appoints Thomas P. Mathers as Chief Executive Officer - FierceBiotech http://www.fiercebiotech.com/press-releases/colucid-appoints-thomas-p-mathers-chief-executive-officer#i
July 8, 2011
Marina Biotech Reports Significant Developments in Its Ability to Develop Both microRNA Mimetics and Antagonists
June 26, 2011
A Rare Disease Pioneer Scores $45 Million for New Company
June 24, 2011
Diabetes drug company Lumena raising up to $2M to reach clinical trials
June 24, 2011
N.C. diagnostics firm LipoScience files for $86M IPO
June 22, 2011
Achillion Initiates 12-Week Dosing in Phase 2 Trial of ACH-1625 for the Treatment of Chronic Hepatitis C
June 21, 2011
Tesaro Garners $101,000,000 Series B Financing Round
June 20, 2011
Canada-U.S. syndicate back Milestone Pharma's oral drug for cardiac arrhythmia
June 20, 2011
Ultragenyx Announces Series A Financing
June 17, 2011
Pappas Ventures-Backed Lumena Pharma Bumps up Debt Offering to $2M - cbl
June 16, 2011
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
June 13, 2011
One-Year Follow-Up Results From Athersys' Phase I Study of MultiStem in Heart Attack Patients Presented at International Stem Cell Symposium
June 13, 2011
Milestone completes $13 million round of equity financing
June 11, 2011
Studies find new drugs boost skin-cancer survival
April 4, 2011
Plexxikon, Daiichi Sankyo complete potential $935M deal
April 1, 2011
Taking Aim at Melanoma - The Scientist - Magazine of the Life Sciences
March 30, 2011
Achillion Announces Positive RVR Results With ACH-1625 to Treat Chronic Hepatitis C
March 28, 2011
Selventa Announces a Joint Technology Collaboration with Pfizer Inc., to Include Developing Knowledge-sharing Portal of Bi Read more: Selventa Announces a Joint Technology Collaboration with Pfizer Inc., to Include Developing Knowledge-sharing Portal of
March 8, 2011
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies
March 4, 2011
Liquidia Technologies receives significant equity investment to bolster development of next generation vaccines.
March 1, 2011
Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer
February 28, 2011
Daiichi Sankyo to Acquire Plexxikon
February 16, 2011
Chimerix Awarded BARDA Contract for Advanced Development of CMX001 as Medical Countermeasure Against Smallpox
February 14, 2011
Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157
February 3, 2011
Marina Biotech and The Debiopharm Group Partner to Develop and Commercialize RNAi-Based Therapies for the Treatment of Bladder Cancer
January 19, 2011
Researchers From Case Western Reserve and Athersys Publish Landmark Study Showing Regenerative Benefit of MultiStem Therapy After Spinal Cord Injury
January 18, 2011
Plexxikon Reports Overall Survival Benefit for Melanoma Patients in PLX4032 Phase 3 Trial